XML 28 R17.htm IDEA: XBRL DOCUMENT v3.19.1
Business Segments
3 Months Ended
Mar. 30, 2019
Segment Reporting [Abstract]  
Business Segments

10. Business Segments

The Company operates in one segment, ophthalmology. The Company develops, manufactures and markets medical devices. Our revenues arise from the sale of consoles, delivery devices, consumables, service, and support activities.

Revenue information shown by product group is as follows:

 

 

 

Three Months Ended

 

(in thousands)

 

March 30, 2019

 

 

March 31, 2018

 

G6

 

$

3,106

 

 

$

2,841

 

Retina

 

 

5,599

 

 

 

4,911

 

Other(1)

 

 

1,890

 

 

 

1,757

 

Total revenues

 

$

10,595

 

 

$

9,509

 

(1) Incudes service contract revenues of $308 and $304 recognized during the three months ended March 30, 2019 and March 31, 2018, respectively. Other also includes revenues from paid service, royalty, freight and legacy G probes.

 

 

Revenue information shown by geographic region, based on the sales destination, is as follows:

 

 

 

Three Months Ended

 

(in thousands)

 

March 30, 2019

 

 

March 31, 2018

 

United States

 

$

5,202

 

 

$

4,860

 

Europe

 

 

2,477

 

 

 

2,434

 

Rest of Americas

 

 

618

 

 

 

652

 

Asia/Pacific Rim

 

 

2,298

 

 

 

1,563

 

Total revenues

 

$

10,595

 

 

$

9,509

 

 

Revenues are attributed to countries based on location of end customers.

Other than the United States, no individual country accounted for more than 10% of the Company’s revenues during the three months ended March 30, 2019 and March 31, 2018.  The United States accounted for 49.1% and 51.1% of revenues for the three months ended March 30, 2019 and March 31, 2018, respectively.   International sales accounted for 50.9% and 48.9% of revenues for the three months ended March 30, 2019 and March 31, 2018, respectively.